Profound Medical Corp

Research Profound Medical Corp (PROF) on Bullrun: market cap USD 239.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPROF
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 239.46M
• Financial periodFY2025
• RevenueUSD 16.10M
• Revenue growth65.3%
• Net income-USD 42.57M
• Free cash flow-USD 38.38M
• Gross margin70.8%

Valuation Snapshot

latest market cap is USD 239.46M.

About Profound Medical Corp

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.

Frequently asked questions

What is Profound Medical Corp's market cap?

Profound Medical Corp's market capitalization is USD 239.46M.

What does Profound Medical Corp do?

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.